Mild Dementia clinical trials

Explore recruiting mild dementia clinical trials.

Recruiting mild dementia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mild Dementia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alzheimer’s disease (AD)

France, Netherlands, Spain, Italy, Poland, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)

Italy, Bulgaria, Romania, Portugal, Hungary, Ireland +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)

Romania, Bulgaria, Belgium, Croatia, France, Greece +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants with Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD)

Spain, Poland, Italy, Denmark, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Multicenter, Randomized, Double blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants with Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)

Poland, France, Germany, Netherlands, Spain, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric and functional outcomes of Ambroxol in New and Early patients with prodromal and mild Dementia with Lewybodies (The ANeED study)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Mild Dementia trials by city

Mild Dementia in Toronto Mild Dementia in Vancouver Mild Dementia in Montreal Mild Dementia in Calgary Mild Dementia in Edmonton Mild Dementia in Ottawa Mild Dementia in Winnipeg Mild Dementia in Quebec City Mild Dementia in Hamilton Mild Dementia in Kitchener Mild Dementia in London Mild Dementia in Halifax Mild Dementia in New York Mild Dementia in Los Angeles Mild Dementia in Chicago Mild Dementia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease